- Home
- / Zhejiang Wolwo Bio-Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhejiang Wolwo Bio-Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥24.1
2024-10-29
Market Capitalization
¥12.3 B
2024-10-29
Revenue
¥1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 495.7M | 631.2M | 630.2M | 800.3M | 890.3M | 835.0M | 911.7M | 1.0B |
| Cost of goods sold | 28.5M | 22.9M | 28.5M | 34.4M | 41.3M | 40.2M | 44.8M | 50.6M |
| Gross profit | 469.5M | 613.2M | 604.4M | 769.5M | 850.2M | 802.2M | 870.9M | 1.0B |
| Gross profit margin, % | 97.1% | 95.9% | 96.1% | 95.5% | 96.1% | 95.5% | 95.5% | |
| Operating expense total | 207.7M | 282.9M | 308.3M | 400.8M | 480.8M | 460.1M | 507.8M | 550.0M |
| Depreciation and amortization | 8.3M | 12.1M | 16.1M | 21.1M | 23.1M | 33.6M | 45.1M | 50.0M |
| EBITDA | 261.8M | 330.3M | 296.1M | 368.7M | 364.5M | 337.9M | 361.5M | 449.3M |
| EBITDA margin, % | 52.3% | 47.0% | 46.1% | 40.9% | 40.5% | 39.6% | 42.9% | |
| EBIT | 254.0M | 319.7M | 298.1M | 364.5M | 370.9M | 314.6M | 330.6M | 407.1M |
| EBIT margin, % | 50.6% | 47.3% | 45.5% | 41.7% | 37.7% | 36.3% | 38.9% | |
| Interest income | 11.3M | 24.2M | 23.3M | 22.6M | 24.8M | 31.0M | 31.8M | 23.7M |
| Interest expense | 362.0K | 444.0K | 1.3M | 1.1M | 793.0K | |||
| Pre tax profit | 273.0M | 345.7M | 322.6M | 393.0M | 398.7M | 346.0M | 365.1M | 432.7M |
| Income tax expense | 41.1M | 53.1M | 52.9M | 66.7M | 63.0M | 50.4M | 60.7M | 64.6M |
| Net Income | 231.9M | 292.6M | 269.7M | 326.3M | 335.7M | 295.5M | 304.3M | 368.1M |